Christine Cooper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christine Cooper has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Alexia Duarte
Universidade Federal do Paraná (UFPR), Curitiba, Brazil
1 shared publication - Alissa Buhrmann
Institute of Neurogenetics, University of Lübeck, 23562 Lübeck, Germany
1 shared publication - Anne Weissbach
Institute of Systems Motor Science, Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany
1 shared publication Barbara Marebwa
Department of Neurology, Medical University of South Carolina, Charleston, South Carolina
1 shared publication- Cherry H. Yu
Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
1 shared publication - Christine Klein
Institute of Neurogenetics, University of Luebeck
1 shared publication
Latest Publications
- Open Access
- 25 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9) , 4074
Genotype–Phenotype Relations for the Dystonia-Parkinsonism Genes GLB1, SLC6A3, SLC30A10, SLC39A14, and PLA2G6: MDSGene Systematic Review
The Movement Disorders Society recommends the DYT/PARK prefix for genes where dystonia and parkinsonism are prominent in approximately half or more of patients. This systematic review explores the genotype–phenotype correlations of GLB1, SLC6A3, SLC30A10, PLA2G6, and SLC39A14—recently classified as DYT SLC39A14 and historically linked to dystonia-parkinsonism. We searched PubMed and the Human Gene Mutation Database using standardized terms, including English-language, peer-reviewed publications up to February 2024. Following the MDSGene protocol, we extracted individual-level data on patients with biallelic pathogenic variants and at least one movement disorder. Features were marked “missing” if not explicitly reported. Of 1828 articles, 128 were eligible. We identified 386 patients and 262 variants. The median age at onset was 3 years for GLB1, 3 months for SLC6A3, 2.5 years for SLC30A10, 1.5 years for SLC39A14, and 16 years for PLA2G6. Missing data may reflect underreporting of negative findings. Case reports/serie, may bias toward atypical presentations. Our analysis showed dystonia-parkinsonism predominates in SLC6A3 and PLA2G6, while GLB1, SLC30A10, and SLC39A1 show predominantly dystonic phenotypes with a low frequency of parkinsonism. Ataxia was common in GLB1 and PLA2G6. Awareness of these phenotypes is essential for early diagnosis and intervention, particularly in treatable conditions like SLC30A10 or SLC39A14. The predominantly dystonic phenotype in GLB1, SLC30A10, and SLC39A14 suggest that the DYT prefix may be more appropriate, highlighting the need to reconsider their nomenclature, and the importance of systematic reviews.
- 25 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9) , 4074
Open AccessGenotype–Phenotype Relations for the Dystonia-Parkinsonism Genes GLB1, SLC6A3, SLC30A10, SLC39A14, and PLA2G6: MDSGene Systematic Review
The Movement Disorders Society recommends the DYT/PARK prefix for genes where dystonia and parkinsonism are prominent in approximately half or more of patients. This systematic review explores the genotype–phenotype correlations of GLB1, SLC6A3, SLC30A10, PLA2G6, and SLC39A14—recently classified as DYT SLC39A14 and historically linked to dystonia-parkinsonism. We searched PubMed and the Human Gene Mutation Database using standardized terms, including English-language, peer-reviewed publications up to February 2024. Following the MDSGene protocol, we extracted individual-level data on patients with biallelic pathogenic variants and at least one movement disorder. Features were marked “missing” if not explicitly reported. Of 1828 articles, 128 were eligible. We identified 386 patients and 262 variants. The median age at onset was 3 years for GLB1, 3 months for SLC6A3, 2.5 years for SLC30A10, 1.5 years for SLC39A14, and 16 years for PLA2G6. Missing data may reflect underreporting of negative findings. Case reports/serie, may bias toward atypical presentations. Our analysis showed dystonia-parkinsonism predominates in SLC6A3 and PLA2G6, while GLB1, SLC30A10, and SLC39A1 show predominantly dystonic phenotypes with a low frequency of parkinsonism. Ataxia was common in GLB1 and PLA2G6. Awareness of these phenotypes is essential for early diagnosis and intervention, particularly in treatable conditions like SLC30A10 or SLC39A14. The predominantly dystonic phenotype in GLB1, SLC30A10, and SLC39A14 suggest that the DYT prefix may be more appropriate, highlighting the need to reconsider their nomenclature, and the importance of systematic reviews.
- 30 July 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 127, 107082
Genetic influence on microstructure integrity and motor progression in Parkinson's disease
- 30 July 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 127, 107082
Genetic influence on microstructure integrity and motor progression in Parkinson's disease
- Open Access
- 13 September 2019
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 67 (12) , 2666
Comment on Physical Performance in Memory Clinic Patients: The Potential Role of the White Matter Network
See the Reply by Verwer et al .
- 13 September 2019
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 67 (12) , 2666
Open AccessComment on Physical Performance in Memory Clinic Patients: The Potential Role of the White Matter Network
See the Reply by Verwer et al .